Glucagon like Peptide (GLP)-2 Treatment Improves Liver and Bile Duct Injury in the Mdr2-/- Mouse Model of Sclerosing Cholangitis

被引：0
|
作者：
Menz, Moritz [1 ]
Hinterleitner, Lorenz [1 ]
Koenigshofer, Philipp [1 ]
Halilbasic, Emina [1 ]
Kunczer, Victoria [2 ]
Stojakovic, Tatjana [3 ]
Reiberger, Thomas [2 ]
Fuchs, Claudia Daniela [2 ]
Trauner, Michael H. [2 ]
机构：
[1] Med Univ Vienna, Intemal Med 3, Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[3] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1453
引用
收藏
页码：831A / 831A
页数：1
相关论文
共 50 条
  • [41] Add-on Norursodeoxycholic Acid Mitigates Liver Injury Induced By High Dose Ursodeoxycholic Monotherapy in the Mdr2 Knockout Mouse Model of Sclerosing Cholangitis
    Halilbasic, Emina
    Fuchs, Claudia Daniela
    Auer, Thierry Claude Nicole
    Leditznig, Nadja
    Trauner, Michael H.
    HEPATOLOGY, 2018, 68 : 871A - 872A
  • [42] MANIPULATION OF THE MIR-16/FGF-1 AXIS REDUCES PROFIBROTIC, PROLIFERATIVE, AND INFLAMMATORY PHENOTYPES IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
    O'Brien, April
    White, Tori
    Kyritsi, Konstantina
    Francis, Heather L.
    Zhou, Tianhao
    Chakraborty, Sanjukta
    Meng, Fanyin
    Alpini, Gianfranco
    Glaser, Shannon S.
    HEPATOLOGY, 2020, 72 : 309A - 310A
  • [43] Biliary leakage of fluorescent bile acids in MDR2 knockout mice: Evidence for a critical role of bile duct leakage in the pathogenesis of sclerosing cholangitis
    Fickert, P
    Fuchsbichler, A
    Wagner, M
    Zollner, G
    Kaser, A
    Tilg, H
    Krause, R
    Langner, C
    Zatloukal, K
    Marschall, HU
    Denk, H
    Trauner, M
    JOURNAL OF HEPATOLOGY, 2004, 40 : 91 - 91
  • [44] LONG-TERM ADMINISTRATION OF THE SECRETIN RECEPTOR ANTAGONIST, SCT 5-27, INHIBITS BILIARY SENESCENCE AND LIVER FIBROSIS OF PRIMARY SCLEROSING CHOLANGITIS (PSC) IN THE MDR2-/- MOUSE MODEL.
    Wu, Nan
    Kennedy, Lindsey
    Zhou, Tianhao
    Kyritsi, Konstantina
    Chen, Lixian
    Ceci, Ludovica
    Grumbles, Kassidy
    Francis, Heather L.
    Meadows, Vik
    Meng, Fanyin
    Ekser, Burcin
    O'Brien, April
    Rivosecchi-Fulton, Jessica
    Onori, Paolo
    Gaudio, Eugenio
    White, Tori
    Glaser, Shannon S.
    Alpini, Gianfranco
    GASTROENTEROLOGY, 2020, 158 (06) : S1277 - S1277
  • [45] Inhibition of H2 histamine receptor by Vivo-Morpholino treatment decreases mast cell activation, large biliary proliferation, angiogenesis, fibrosis and inflammation in the Mdr2-/- mouse model of primary sclerosing cholangitis
    Kennedy, Lindsey
    Demieville, Jennifer
    Hargrove, Laura
    Meng, Fanyin
    Alpini, Gianfranco
    Smith, Steven
    Francis, Heather L.
    HEPATOLOGY, 2017, 66 : 110A - 110A
  • [46] INHIBITION OF TRANSFORMING GROWTH FACTOR BETA 1 (TGFβ1) BY VIVO-MORPHOLINO (VM) AMELIORATES CHOLESTASIS IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Chen, Lixian
    Zhou, Tianhao
    Kundu, Debjyoti
    Meadows, Vik
    Kennedy, Lindsey
    Kyritsi, Konstantina
    Wu, Nan
    Meyer, Alison A.
    Owen, Travis M.
    Alpini, Gianfranco
    Francis, Heather L.
    GASTROENTEROLOGY, 2022, 162 (07) : S1216 - S1216
  • [47] FXR BUT NOT TGR5 ACTIVATION STIMULATES HCO3-RICH BILE SECRETION AND AMELIORATES LIVER DAMAGE IN MDR2-/- (ABCB4-/-) MOUSE MODEL OF CHRONIC LIVER INJURY
    Baghdasaryan, Anna
    Claudel, Thierry
    Gumhold, Judith
    Silbert, Dagmar
    Adorini, Luciano
    Gonzalez, Frank
    Schoonjans, Kristina
    Fickert, Peter
    Trauner, Michael
    HEPATOLOGY, 2011, 54 : 425A - 425A
  • [48] Sex-Hormone Dependent Intestinal Expression of Asbt Determines the Sclerosing Cholangitis Phenotype and the Response to Pharmacological Disruption of Enterohepatic Circulation of Bile Acids in Mdr2-/- Mice
    Arce-Clachari, Ana Catalina
    Mullen, Mary
    Shi, Tiffany
    Matuschek, Nelson
    Kudira, Ramesh
    Lages, Celine Silva
    Zhang, Wujuan
    Simmons, Julia
    Karns, Rebekah
    Shanmukhappa, Kumar
    Setchell, Kenneth David Reginald
    Miethke, Alexander G.
    HEPATOLOGY, 2018, 68 : 1353A - 1353A
  • [49] Mycophenolate mofetil is antifibrotic at low but profibrogenic at higher clinical doses in the Mdr2-/- mouse model of liver fibrosis
    Popov, Yury
    Millonig, Gunda
    Khokhar, Asim
    Zaks, Jessica
    Bhaskar, Killimangalam
    Sverdlov, Deanna
    Schuppan, Detlef
    GASTROENTEROLOGY, 2007, 132 (04) : A826 - A826
  • [50] Comparative potential of soybean lecithin and ursodeoxycholic acid against the progression of liver disease in the Mdr2-/- mouse model
    Martel, M
    St-Hilaire, W
    Tuchweber, B
    Bouchard, G
    GASTROENTEROLOGY, 2005, 128 (04) : A260 - A260
12345